You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium
|
|---|---|
| Published in |
Annals of Oncology, July 2014
|
| DOI | 10.1093/annonc/mdu276 |
| Pubmed ID | |
| Authors |
C. Bosetti, V. Rosato, D. Li, D. Silverman, G.M. Petersen, P.M. Bracci, R.E. Neale, J. Muscat, K. Anderson, S. Gallinger, S.H. Olson, A.B. Miller, H. Bas Bueno-de-Mesquita, G. Scelo, V. Janout, I. Holcatova, P. Lagiou, D. Serraino, E. Lucenteforte, E. Fabianova, P.A. Baghurst, W. Zatonski, L. Foretova, E. Fontham, W.R. Bamlet, E.A. Holly, E. Negri, M. Hassan, A. Prizment, M. Cotterchio, S. Cleary, R.C. Kurtz, P. Maisonneuve, D. Trichopoulos, J. Polesel, E.J. Duell, P. Boffetta, C. La Vecchia, P. Ghadirian |
| Abstract |
Type 2 diabetes mellitus has been associated with an excess risk of pancreatic cancer, but the magnitude of the risk and the time-risk relationship are unclear, and there is limited information on the role of antidiabetic medications. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| Australia | 1 | 13% |
| United States | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Scientists | 2 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 255 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 40 | 16% |
| Student > Bachelor | 37 | 15% |
| Researcher | 28 | 11% |
| Student > Master | 23 | 9% |
| Student > Doctoral Student | 20 | 8% |
| Other | 40 | 16% |
| Unknown | 67 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 90 | 35% |
| Biochemistry, Genetics and Molecular Biology | 41 | 16% |
| Agricultural and Biological Sciences | 15 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
| Social Sciences | 4 | 2% |
| Other | 19 | 7% |
| Unknown | 80 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2021.
All research outputs
#1,214,359
of 25,775,807 outputs
Outputs from Annals of Oncology
#564
of 7,903 outputs
Outputs of similar age
#11,637
of 240,602 outputs
Outputs of similar age from Annals of Oncology
#8
of 148 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,903 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 240,602 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 148 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.